ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
831
Screening encounters
837
Diagnostic referrals
150
Outstanding pathways
97

Screening pathway

  1. Screening837Encounters
  2. Positive finding277Documented findings
  3. Referral150Diagnostic referrals
  4. Follow-up126Diagnostic visits
  5. Outcome53Resolved pathways

Stage totals use different units. Pending pathways: 97. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0484 · EXP-0484Synthetic · Site A

Full participant history through 2025-05-31, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-09-21
  4. · Diagnostic referral · EXP-0484-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Missed

Referral-time risk

Pathway status at observation · Pending

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

831 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0996 · Expanded synthetic participant 0996Site D — Community Engagement Programme
EXP-0998 · Expanded synthetic participant 0998Site C — Rural Outreach Programme
EXP-1005 · Expanded synthetic participant 1005Site D — Community Engagement Programme
EXP-1017 · Expanded synthetic participant 1017Site D — Community Engagement Programme
EXP-1029 · Expanded synthetic participant 1029Site A — Urban Referral Hub
EXP-1033 · Expanded synthetic participant 1033Site D — Community Engagement Programme
EXP-1039 · Expanded synthetic participant 1039Site B — Peri-Urban Access Programme
EXP-1050 · Expanded synthetic participant 1050Site D — Community Engagement Programme
EXP-1056 · Expanded synthetic participant 1056Site A — Urban Referral Hub
EXP-1072 · Expanded synthetic participant 1072Site D — Community Engagement Programme
EXP-1082 · Expanded synthetic participant 1082Site E — Resource-Constrained Navigation Programme
EXP-1093 · Expanded synthetic participant 1093Site A — Urban Referral Hub
EXP-1096 · Expanded synthetic participant 1096Site D — Community Engagement Programme
EXP-1097 · Expanded synthetic participant 1097Site B — Peri-Urban Access Programme
EXP-1102 · Expanded synthetic participant 1102Site B — Peri-Urban Access Programme
EXP-1105 · Expanded synthetic participant 1105Site C — Rural Outreach Programme
EXP-1109 · Expanded synthetic participant 1109Site A — Urban Referral Hub
EXP-1116 · Expanded synthetic participant 1116Site B — Peri-Urban Access Programme
EXP-1117 · Expanded synthetic participant 1117Site D — Community Engagement Programme
EXP-1130 · Expanded synthetic participant 1130Site E — Resource-Constrained Navigation Programme
EXP-1131 · Expanded synthetic participant 1131Site B — Peri-Urban Access Programme
EXP-1142 · Expanded synthetic participant 1142Site C — Rural Outreach Programme
EXP-1163 · Expanded synthetic participant 1163Site C — Rural Outreach Programme
EXP-1167 · Expanded synthetic participant 1167Site D — Community Engagement Programme
EXP-1171 · Expanded synthetic participant 1171Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
378
HPV DNA
337
Cytology
122

Navigation activity

Barrier documented
111
Contact attempt
211
Navigation intervention
41
Diagnostic booking
172
Diagnostic visit
126

Documented barriers

Contact difficulty
31
Transport difficulty
39
Appointment coordination
41

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.